Michael D. Lockshin

Michael D. Lockshin's AcademicInfluence.com Rankings

Michael D. Lockshin

Philosophy

#6604

World Rank

#9666

Historical Rank

#1544

USA Rank

Logic

#3745

World Rank

#4946

Historical Rank

#728

USA Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Michael D. Lockshin Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Michael D. Lockshin is an American professor and medical researcher. He is known for his work as a researcher of autoimmune diseases, with focus on antiphospholipid syndrome and lupus. He is Professor Emeritus of Medicine and the Director Emeritus of the Barbara Volcker Center for Women and Rheumatic Disease at Hospital for Special Surgery. He retired from HSS on January 31st, 2023.

(See a Problem?)

Michael D. Lockshin's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) (2006) (4892)
International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. (1999) (2685)
The classification of glomerulonephritis in systemic lupus erythematosus revisited. (2004) (1926)
The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. (1999) (1841)
Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. (2003) (1439)
The classification of glomerulonephritis in systemic lupus erythematosus revisited. (2004) (1141)
Combined Oral Contraceptives in Women With Systemic Lupus Erythematosus (2005) (958)
The Effect of Combined Estrogen and Progesterone Hormone Replacement Therapy on Disease Activity in Systemic Lupus Erythematosus: A Randomized Trial (2005) (577)
Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus. (1985) (557)
Anti-inflammatory and immunosuppressive drugs and reproduction (2006) (548)
Association between polyarteritis and Australia antigen. (1970) (513)
Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals. (2007) (369)
Studies of twins with systemic lupus erythematosus. A review of the literature and presentation of 12 additional sets. (1975) (343)
Preclinical Carotid Atherosclerosis in Patients with Rheumatoid Arthritis (2006) (326)
A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome. (2002) (320)
Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies. (2012) (311)
Arterial Stiffness in Chronic Inflammatory Diseases (2005) (305)
14th International Congress on Antiphospholipid Antibodies: task force report on antiphospholipid syndrome treatment trends. (2014) (294)
Systemic Lupus Erythematosus: Emerging Concepts: Part 1: Renal, Neuropsychiatric, Cardiovascular, Pulmonary, and Hematologic Disease (1995) (291)
Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody. (1989) (253)
Lupus pregnancy. Case-control prospective study demonstrating absence of lupus exacerbation during or after pregnancy. (1984) (248)
2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases (2020) (236)
VASCULITIS WITH HEPATITIS B ANTIGENEMIA: Long-term Observations in Nine Patients (1976) (232)
Predictors of Pregnancy Outcomes in Patients With Lupus (2015) (225)
A pilot open-label phase II trial of rituximab for non-criteria manifestations of antiphospholipid syndrome. (2013) (218)
Validation of the Sapporo criteria for antiphospholipid syndrome. (2000) (211)
High thrombosis rate after fetal loss in antiphospholipid syndrome: effective prophylaxis with aspirin. (2001) (197)
Identification of mothers at risk for congenital heart block and other neonatal lupus syndromes in their children. Comparison of enzyme-linked immunosorbent assay and immunoblot for measurement of anti-SS-A/Ro and anti-SS-B/La antibodies. (1993) (191)
Antiphospholipid antibody syndrome: immunologic and clinical aspects. (1990) (186)
Central nervous system disease in systemic lupus erythematosus. Therapy and prognosis. (1975) (181)
Assessing disease activity in SLE patients during pregnancy (1999) (176)
Update on safety during pregnancy of biological agents and some immunosuppressive anti-rheumatic drugs. (2008) (167)
Systemic Lupus Erythematosus: Emerging Concepts: Part 2: Dermatologic and Joint Disease, the Antiphospholipid Antibody Syndrome, Pregnancy and Hormonal Therapy, Morbidity and Mortality, and Pathogenesis (1995) (165)
Rate and determinants of progression of atherosclerosis in systemic lupus erythematosus. (2007) (164)
Pregnancy does not cause systemic lupus erythematosus to worsen. (1989) (155)
Letter: Lymphocyte response. (1974) (154)
Placental pathology in systemic lupus erythematosus: a prospective study. (1998) (151)
Ovulation induction and in vitro fertilization in systemic lupus erythematosus and antiphospholipid syndrome. (2000) (151)
Neonatal lupus risk to newborns of mothers with systemic lupus erythematosus. (1988) (149)
Long term outcome of catastrophic antiphospholipid syndrome survivors (2003) (136)
The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: measures of overall disease activity. (2004) (135)
Aortic insufficiency and mitral regurgitation in patients with systemic lupus erythematosus and the antiphospholipid syndrome. (1989) (129)
Antibody to cardiolipin, lupus anticoagulant, and fetal death. (1987) (128)
Sensitivity to metal as a possible cause of sterile loosening after cobalt-chromium total hip-replacement arthroplasty. (1977) (128)
Vasculitis in association with Australia antigen. (1971) (127)
High-dose intravenous methylprednisolone pulse therapy in systemic lupus erythematosus. (1981) (127)
Relationship between serum NR2a antibodies and cognitive dysfunction in systemic lupus erythematosus. (2006) (123)
Effects of mothers' autoimmune disease during pregnancy on learning disabilities and hand preference in their children. (2003) (122)
Cardiac disease in the antiphospholipid syndrome: recommendations for treatment. Committee consensus report (2003) (120)
Pregnancy and reproduction in autoimmune rheumatic diseases. (2011) (120)
Relationship of antiphospholipid antibodies to cardiovascular manifestations of systemic lupus erythematosus. (2006) (118)
Occlusive vasculopathy in systemic lupus erythematosus. Association with anticardiolipin antibody. (1991) (116)
Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study. (2016) (112)
Prevalence and relation to risk factors of carotid atherosclerosis and left ventricular hypertrophy in systemic lupus erythematosus and antiphospholipid antibody syndrome. (2001) (110)
Lupus anticoagulant is the main predictor of adverse pregnancy outcomes in aPL-positive patients: validation of PROMISSE study results (2016) (107)
The diversity of neurologic events in systemic lupus erythematosus. Prospective clinical and computed tomographic classification of 82 events in 71 patients. (1986) (106)
Independent association of rheumatoid arthritis with increased left ventricular mass but not with reduced ejection fraction. (2009) (99)
Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and/or antiphospholipid antibodies (2018) (98)
Perioperative medical management of antiphospholipid syndrome: hospital for special surgery experience, review of literature, and recommendations. (2002) (96)
Assessment of the 2006 revised antiphospholipid syndrome classification criteria (2007) (86)
Serologic studies of monozygotic twins with systemic lupus erythematosus. (1992) (82)
Answers to the antiphospholipid-antibody syndrome? (1995) (81)
Primary antiphospholipid syndrome: functional outcome after 10 years. (2000) (80)
The antiphospholipid syndrome as a disorder initiated by inflammation: implications for the therapy of pregnant patients (2007) (79)
Challenges of lupus pregnancies. (2008) (79)
Central nervous system lupus erythematosus. The need for classification. (1979) (77)
Antiphospholipid Antibodies Differ in aPL Cofactor Requirement (1992) (76)
Cell-mediated immunity in rheumatic diseases (1975) (75)
Measuring systemic lupus erythematosus activity during pregnancy: validation of the lupus activity index in pregnancy scale. (2004) (75)
Management of the controversial aspects of the antiphospholipid syndrome pregnancies: a guide for clinicians and researchers. (2008) (75)
Pregnancy Loss in the Antiphospholipid Syndrome (1999) (74)
"End-stage" lupus nephritis: clinical course to and outcome on dialysis. Experience with 39 patients. (1981) (74)
Systemic Lupus Erythematosus Predicts Increased Left Ventricular Mass (2007) (73)
Neurologic complications of antiphospholipid antibodies. (1993) (71)
2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases (2020) (71)
New approaches for managing antiphospholipid syndrome (2009) (69)
Real world experience with antiphospholipid antibody tests: how stable are results over time? (2005) (68)
Rheumatoid meningitis: a localized immune process. (1979) (65)
Treatment of the antiphospholipid syndrome. (2003) (65)
Lupus pregnancy. II. Unusual pattern of hypocomplementemia and thrombocytopenia in the pregnant patient. (1985) (62)
Diffusion changes in patients with systemic lupus erythematosus. (2007) (62)
IgG subclass and light chain distribution of anticardiolipin and anti-DNA antibodies in systemic lupus erythematosus. (1988) (62)
Kidney Outcomes and Risk Factors for Nephritis (Flare/De Novo) in a Multiethnic Cohort of Pregnant Patients with Lupus. (2017) (61)
Lupus anticoagulant–hypoprothrombinemia syndrome associated with systemic lupus erythematosus: report of 2 cases and review of literature (1999) (61)
Cellular immunity in rheumatic diseases. I. Rheumatoid arthritis. (1973) (60)
Non-criteria manifestations of antiphospholipid syndrome (2010) (59)
Immunologic observations on 9 sets of twins either concordant or discordant for SLE. (1976) (58)
Neonatal lupus erythematosus with heart block: family study of a patient with anti-SS-A and SS-B antibodies. (1983) (56)
APS ACTION – AntiPhospholipid Syndrome Alliance For Clinical Trials and InternatiOnal Networking (2012) (56)
Which patients with antiphospholipid antibody should be treated and how? (1993) (55)
Characteristics of IgG antiphospholipid antibodies in patients with systemic lupus erythematosus and syphilis. (1990) (55)
Protein-losing enteropathy in systemic lupus erythematosus: report of a severe, persistent case and review of pathophysiology (2002) (52)
Systemic lupus erythematosus in men. Genetic and endocrine features. (1982) (50)
Characteristics of human immunodeficiency virus and chlorpromazine induced antiphospholipid antibodies: effect of beta 2 glycoprotein I on binding to phospholipid. (1994) (50)
A preliminary study of etanercept in the treatment of severe, resistant psoriatic arthritis. (2000) (50)
Lupus Pregnancy (2003) (49)
Corticosteroids during pregnancy. (1998) (48)
Antiphospholipid antibody. Babies, blood clots, biology. (1997) (48)
Characteristics of high-titer IgG antiphospholipid antibody in systemic lupus erythematosus patients with and without fetal death. (1990) (46)
Apparent acute renal failure associated with therapeutic aspirin and ibuprofen administration. (1979) (46)
Trends in Maternal and Fetal Outcomes Among Pregnant Women With Systemic Lupus Erythematosus in the United States (2019) (43)
Anticardiolipin antibody and stroke: possible relation of valvular heart disease and embolic events. (1991) (43)
Hazards of lupus pregnancy. (1987) (43)
2019 American College of Rheumatology Reproductive Health in Rheumatic and Musculoskeletal Diseases Guideline. (2020) (42)
New treatments for antiphospholipid syndrome. (2006) (42)
Reversible "end-stage" lupus nephritis. Analysis of patients able to discontinue dialysis. (1983) (42)
Contribution of Socioeconomic Status to Racial/Ethnic Disparities in Adverse Pregnancy Outcomes Among Women With Systemic Lupus Erythematosus (2018) (41)
Update on antiphospholipid syndrome. (2008) (41)
Invited review: sex ratio and rheumatic disease. (2001) (41)
Arthritis & rheumatism +/- 50. (2008) (41)
Why women? (1995) (41)
Cardiac involvement in the antiphospholipid syndrome (2003) (41)
Sex differences in autoimmune disease (2006) (41)
Relationship of asymmetric dimethylarginine and homocysteine to vascular aging in systemic lupus erythematosus patients. (2010) (40)
Cardiac manifestations in the antiphospholipid syndrome. (2006) (40)
Second-trimester fetal monitoring and preterm delivery in pregnancies with systemic lupus erythematosus and/or circulating anticoagulant. (1987) (38)
Sex ratio and rheumatic disease. (2001) (37)
Atherosclerosis and lupus: a work in progress. (2001) (37)
Patients with overlap autoimmune disease differ from those with ‘pure’ disease (2015) (36)
Reality Check on Antiphospholipid Antibodies in COVID‐19–Associated Coagulopathy (2020) (36)
Pathogenesis of the Antiphospholipid Antibody Syndrome (1996) (36)
Low frequency of flares during pregnancy and post-partum in stable lupus patients (2020) (35)
Antiphospholipid Syndrome Clinical Research Task Force Report (2011) (35)
Sex ratio and rheumatic disease: excerpts from an Institute of Medicine report (2002) (34)
Delayed hypersensitivity in hay-fever. (1970) (33)
Moderate versus high-titer persistently anticardiolipin antibody positive patients: Are they clinically different and does high-titer anti-β2-glycoprotein-I antibody positivity offer additional predictive information? (2010) (33)
Antiphospholipid antibody syndrome. (1994) (33)
Pregnancy in lupus. (1999) (33)
What is antiphospholipid syndrome? (2004) (32)
Development of a New International Antiphospholipid Syndrome Classification Criteria Phase I/II Report: Generation and Reduction of Candidate Criteria (2020) (31)
Pregnancy loss and antiphospholipid antibodies (1998) (29)
Phospholipid binding of antiphospholipid antibodies and placental anticoagulant protein (2004) (29)
Diplopia as early sign of temporal arteritis. Report of two cases. (1970) (29)
American Society for Reproductive Immunology Report of the Committee for Establishing Criteria for Diagnosis of Reproductive Autoimmune Syndrome (1999) (28)
Brief Report: Changes in Antiphospholipid Antibody Titers During Pregnancy: Effects on Pregnancy Outcomes (2016) (28)
Longitudinal evaluation of diffusion tensor imaging and cognition in systemic lupus erythematosus (2018) (27)
Azathioprine-induced meningitis in systemic lupus erythematosus. (1978) (27)
Biology of the sex and age distribution of systemic lupus erythematosus. (2007) (27)
Responses of Fractionated Cells from Patients with Systemic Lupus Erythematosus and Normals to Plant Mitogen: Evidence for a Suppressor Population of Monocytes 1 (1978) (27)
15th International Congress on Antiphospholipid Antibodies Task Force on Antiphospholipid Syndrome Treatment Trends Report (2017) (27)
Failure to Demonstrate Leukocyte Migration Inhibition in Human Tuberculin Hypersensitivity 1 (1969) (26)
Cognitive dysfunction in antiphospholipid antibody (aPL)-negative systemic lupus erythematosus (SLE) versus aPL-positive non-SLE patients. (2014) (26)
Does Lupus Flare during Pregnancy? (1993) (26)
In vitro and in vivo cellular immunity in anergic miliary tuberculosis. (1973) (26)
Perioperative Management of Antiphospholipid Antibody-Positive Patients (2014) (25)
Anticardiolipin antibody. (1987) (25)
Antiphospholipid antibody and antiphospholipid antibody syndrome (1991) (25)
Functional Magnetic Resonance Imaging of Working Memory and Executive Dysfunction in Systemic Lupus Erythematosus and Antiphospholipid Antibody–Positive Patients (2016) (24)
Rheumatology Education in United States Medical Schools (1981) (21)
Therapy for systemic lupus erythematosus. (1991) (20)
Hypocomplementemia with low Cls‐Cl inhibitor complex in systemic lupus erythematosus (1986) (19)
Lupus and antiphospholipid antibody syndrome: either, neither, or both. (1994) (18)
Cognitive dysfunction and white matter abnormalities in antiphospholipid syndrome. (2011) (18)
SLE: reconciling heterogeneity (2019) (18)
Etanercept in the treatment of severe, resistant psoriatic arthritis: continued efficacy and changing patterns of use after two years. (2002) (18)
Auto-immunological basis of disk degeneration. (1976) (18)
Isolation and characterization of circulating immune complexes in patients with hepatitis B systemic vasculitis. (1981) (16)
Posterior compartment syndrome resulting from a dissecting popliteal cyst. Case report. (1977) (16)
Nonhormonal explanations for sex discrepancy in human illness (2010) (16)
COVID-19 and antiphospholipid antibodies: A position statement and management guidance from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) (2021) (16)
Anticoagulation in management of antiphospholipid antibody syndrome in pregnancy. (2013) (16)
Statins for the treatment of obstetric complications in antiphospholipid syndrome? (2010) (16)
Erratum: Classification of Lupus Nephritis: The classification of glomerulonephritis in systemic lupus erythematosus revisited (Journal of the American Society of Nephrology (2004) 15 (241-250)) (2004) (16)
Gonococcal arthritis in two patients with active lupus erythematosus. A diagnostic problem. (1971) (16)
Lupus Pregnancy. Case-Control Prospective Study Demonstrating Absence of Lupus Exacerbation during or after Pregnancy (1985) (16)
Site differences in mild cognitive dysfunction (MCD) among patients with systemic lupus erythematosus (SLE) (2013) (16)
Autoimmunity, infertility and assisted reproductive technologies (2004) (15)
Assisted reproductive technology in SLE and APS (2014) (15)
Discontinuation of hydroxychloroquine in older patients with systemic lupus erythematosus: a multicenter retrospective study (2020) (15)
Supressor monocytes in patients with systemic lupus erythematosus. Evidence of suppressor activity associated with a cell-free soluble product of monocytes. (1980) (15)
Cell-mediated immunity in rheumatic diseases. II. Mitogen responses in RA, SLE, and other illnesses: correlation with T- and B-lymphocyte populations. (1975) (14)
Meningitic reactions after azathioprine. (1972) (14)
Education in rheumatology for the primary care physician. (1978) (14)
First international conference on rheumatic diseases in pregnancy. (1993) (14)
Lepromatous Leprosy Mimicking Systemic Lupus Erythematosus (2014) (13)
Occasional Series Why women? (1997) (13)
Update on antiphospholipid syndrome. (2006) (13)
Warfarin in antiphospholipid syndrome--time to explore new horizons. (2005) (13)
The unproven remedies committee. (1981) (13)
Fatty acid chain is a critical epitope for antiphospholipid antibody (1990) (13)
How much warfarin is enough in APS related thrombosis? (2004) (13)
Monocyte-induced inhibition of lymphocyte response to phytohaemagglutinin in progressive systemic sclerosis. (1983) (12)
Catastrophic Antiphospholipid Syndrome Triggered by Sepsis (2009) (12)
Antiphospholipid antibodies and fetal loss. (1992) (12)
Overview of Lupus Pregnancies (1992) (11)
Gender, biology and human disease: report of a conference (1999) (11)
Angiogenic Factor Imbalance Early in Pregnancy Predicts Adverse Outcomes in Patients With Lupus and Antiphospholipid Antibodies: Results of the PROMISSE Study (2016) (11)
Proceedings: Twin studies in systemic lupus erythematosus (SLE). (1975) (10)
Ankylosing spondylitis and HL-A. A genetic disease plus? (1975) (10)
Lupus pregnancy. (2003) (10)
Alternative complement pathway in hypocomplementemic/normal C1s-C1 inhibitor complex patients with SLE. (1990) (10)
VASCULITIS IN ASSOCIATION WITH AUSTRALIA ANTIGEN (1971) (10)
In vitro delayed hypersensitivity in normal and hyporeactive patients. (1971) (10)
Editorial: Treatment of central nervous system lupus erythematosus. (1974) (10)
Lysophosphatidylethanolamine is the antigen to which apparent antibody to phosphatidylethanolamine binds (1990) (10)
Sex differences in autoimmune disease. (2006) (9)
Manpower and fellowship education in rheumatology, 1980. (1981) (9)
Summary of a workshop on the role of third-party payers in clinical trials of new agents. (1983) (9)
Changes in Antiphospholipid Antibody Titers during Pregnancy: Data from the PROMISSE Study (2016) (9)
Erratum: The classification of glomerulonephritis in systemic lupus ereythematosus revisited (Kidney International (2004) 65 (521-530)) (2004) (9)
Treating rheumatic diseases in pregnancy: dos and don’ts (2006) (8)
Endocrine origins of rheumatic disease (2002) (8)
Enhancement of anti-phospholipid antibody activity by Tween 20. (1988) (8)
Splitting headache (off). (2013) (8)
American College of Rheumatology Criteria for Systemic Lupus Erythematosus Exclude Half of All Systemic Lupus Erythematosus Patients (2017) (8)
New journal policy regarding registration of clinical trials. (2005) (8)
Genome and Hormones : Gender Differences in Physiology Invited Review : Sex ratio and rheumatic disease (2001) (7)
Reproductive and hormonal aspects of systemic autoimmune diseases (2006) (7)
Treatment of lupus pregnancy: can we reach consensus? (1992) (7)
Estrogens and lupus: bubbling cauldron or another overrated Witches' Brew? (2007) (7)
Prognosis and Future Directions (2000) (7)
IgG but not IgM anti-phospholipid antibody binding is temperature dependent (1988) (7)
Pregnancy associated with systemic lupus erythematosus. (1990) (7)
Antiphospholipid antibody/lupus anticoagulant workshop. (1992) (7)
Why do women have rheumatic disease? (1998) (7)
Do medical students in the United States learn clinical rheumatology? (1977) (6)
Antiphospholipid Antibody: Future Developments (1994) (6)
Renin-dependent hypertension in polyarteritis nodosa. (1981) (5)
DRG legislation and rheumatic disease. (1984) (5)
Introduction: new trends in pregnancy and rheumatic diseases. (2008) (5)
Lupus anticoagulant—hypoprothrombinemia syndrome and pregnancy (2001) (5)
Why do patients with antiphospholipid antibody clot? (1997) (5)
Lupus pregnancies and neonatal lupus (2004) (5)
Rheumatology education in United States medical school. (1981) (5)
Antiphospholipid Syndrome (2017) (4)
Malnutrition does not ameliorate systemic lupus erythematosus. (1980) (4)
Editorial Why do patients with antiphospholipid antibody clot (1997) (4)
Primary Antiphospholipid Syndrome Presenting as HELLP Syndrome (2007) (4)
Lupus erythematosus and allied disorders in pregnancy. (1987) (4)
Pregnancy in systemic lupus erythematosus. (1989) (4)
Hypocomplementemia with low C1s-C1 inhibitor complex in systemic lupus erythematosus. (1986) (4)
Thrombosis in the antiphospholipid-antibody syndrome. (1995) (4)
Pregnancy and Rheumatic Disease: Experience at a Single Center in New York City During the COVID‐19 Pandemic (2020) (4)
Task Force Report on Antiphospholipid Syndrome Clinical Research (2012) (4)
New developments in lupus-associated antiphospholipid syndrome (2008) (3)
Changes in anti-lymphocyte and anti-Ia antibodies during pregnancy in systemic lupus erythematosus. (1986) (3)
PREGNANCY LOSS IN AUTOIMMUNE DISEASES (1994) (3)
Anticardiolipin antibodies and lupus anticoagulants. (1990) (3)
Mitral Valve Vegetation in Antiphospholipid Syndrome (2016) (3)
Assisted reproductive technologies for women with rheumatic AID. (2019) (3)
Systemic lupus erythematosus in the pregnant patient and neonatal lupus (2011) (3)
Elective Termination of Pregnancy in Autoimmune Rheumatic Diseases: Experience From Two Databases (2020) (3)
Definition and Epidemiology of Antiphospholipid Syndrome (2017) (3)
Treatment of vasculitis with cyclophosphamide. (1979) (3)
Letter: Aspirin and lymphocyte transformation. (1975) (3)
82 – Antiphospholipid Syndrome (2013) (3)
Journal policies on authorship and disclosures. (2006) (3)
Pregnancy and Antiphospholipid Syndrome (2012) (3)
Systemic lupus erythematosus: problems in management. (1982) (3)
Pregnancy and aPL. (1991) (2)
Normal macrophage migration inhibition in dexamethasone-treated guinea-pigs (1972) (2)
Therapy: Antiphospholipid syndrome research needs more collaboration (2014) (2)
Pregnancy and Rheumatic Diseases (2009) (2)
Journal policies on authorship and disclosures. (2006) (2)
Interferon induced digital artery vasculitis. (2005) (2)
Editor's Note: A new look (2008) (2)
Lupus anticoagulant-related conditions. (1989) (2)
History of Antiphospholipid Antibody (2017) (2)
AB0561 Needs-Assessment Survey for the Update of the Current Antiphospholipid Syndrome (APS) Classification Criteria (2015) (2)
When a Diagnosis Has No Name: Uncertainty and Opportunity (2021) (2)
Entry criteria influence conclusions about rates of flare in lupus pregnancy: comment on the article by Petri et al. (1992) (2)
Antiphospholipid antibody syndrome. (1992) (2)
Rheumatoid Arthritis is Independently Associated with Increased Left Ventricular Mass but not Reduced Ejection Fraction (2011) (2)
Preventing antiphospholipid antibody-induced fetal loss: a new idea. (1993) (2)
Fertility in Systemic Lupus Erythematosus (2007) (2)
Future trends for treatment of APS. (2000) (2)
61 – Antiphospholipid syndrome (2008) (2)
Pregnancy and antiphospholipid antibody (2001) (1)
Clinical trial registration and publication of randomized controlled trials. (2010) (1)
Lawrence E. Shulman, MD, PhD, 1919–2009 (2010) (1)
Reply: To PMID 23044629. (2013) (1)
Discussion of Diagnostic Excellence. (2022) (1)
COMBINED CLINICAL AND BASIC SCIENCE SEMINAR (1979) (1)
Management of the Difficult Aspects of the Antiphospholipid Syndrome (2002) (1)
Management of antiphospholipid syndrome in pregnant and postpartum women (2017) (1)
To Eat the Elephant (2019) (1)
The Future of Hughes Syndrome (2006) (1)
Anti-phospholipid Syndrome (2017) (1)
A Tale of Two Worlds (2017) (1)
Differences between acute and chronic disease: comment on the article by Holman (2020) (1)
Georgia Abortion Law and Our Commitment to Patients (2020) (1)
Lupus science and medicine: dialogue (2014) (1)
The frequency of the rheumatic diseases. By Sidney Cobb. Vital and Health Statistics Monographs, American Public Health Association. Cambridge, Massachusetts, Harvard University Press, 1971, 147pp, $5.00 (1972) (1)
Presumptive autonephrectomy in scleroderma. (1979) (1)
Real world experience with aPL : Comparison between APS and asymptomatic aPL-positive patients (2004) (1)
Lupus erythematosus, treatment? (1973) (1)
CS-31 Safety of hydroxychloroquine withdrawal in older adults with systemic lupus erythematosus (2018) (1)
Real world experience with APL-degree of anticardiolipin antibody (ACL) variation between assays (2004) (1)
CS-26 What do we mean when we say SLE? (2018) (1)
Antiphospholipid Syndrome: What Should Patients Know? (2017) (1)
Are posttranslational modifications of β2-glycoprotein I markers for thrombotic risk? Are they triggers of autoimmunity? (2011) (1)
Infectious arthritis. (1982) (0)
The association of food anaphylaxis in antiphospholipid syndrome and thrombosis cannot be considered a coincidence (2011) (0)
Antiphospholipid: to test, or not to test, that is the question (2012) (0)
Cognitive or cosmetic dysfunction? (2012) (0)
Association of accelerated atherosclerosis and myocardial hypertrophy with systemic lupus erythematosus (1998) (0)
60 – Antiphospholipid syndrome (2013) (0)
Chapter 18 Difficult Clinical Situations in the Antiphospholipid Syndrome (2009) (0)
What Should Patients Know about Antiphospholipid Antibodies and Antiphospholipid Syndrome (2012) (0)
Why women? (1997) (0)
List of Contributors (2019) (0)
Other Disorders with Autoimmune Manifestations (1981) (0)
DRG legislation and the physician. (1986) (0)
Introduction (0)
New Perspectives in the Study and Treatment of the Antiphospholipid Syndrome (2018) (0)
Comment on the article by Lockshin. Author reply (1990) (0)
Mechanism of buffy coat migration inhibition test (1973) (0)
Sex ratio and rheumatic disease. (2001) (0)
"David Seegal". (2015) (0)
Annual Research Reviews: Rheumatoid Arthritis and Related Conditions.Edited by Gabriel S. Panayi. Volume 3. Montreal and Edinburgh, Eden Press, Inc., and Churchill Press, 1979. 197 pages. $22.00 (1980) (0)
Current research in rheumatic diseases. (1976) (0)
Abstract 1997: Systemic Lupus Erythematosus Increases Left Ventricular Mass Independent of Traditional Stimuli to Hypertrophy (2006) (0)
Infertility in systemic lupus erythematosus: what rheumatologists need to know in a new age of assisted reproductive technology (2022) (0)
Systemic Lupus Erythematosus (2019) (0)
Systemic Lupus Erythematosus (2019) (0)
PROMIS-29 and Health Related Quality of Life in Rheumatology Outpatients During the COVID-19 Pandemic in New York City (2020) (0)
Increased prednisone reduced minor relapses in systemic lupus erythematosus (1996) (0)
Anatomy of infection (1982) (0)
Remembrances of Predictions Past (2012) (0)
nomenclature of a and r 1983 (2015) (0)
The child, grown, becomes independent. (2009) (0)
Modification of immunomodulatory medications by rheumatology patients during the peak of the COVID-19 pandemic in New York City (2022) (0)
Health Quackery. Consumer Reports Books. Mount Vernon, New York, Consumer's Union, 1980. (1980) (0)
Session 7C: Neonatal Lupus (1992) (0)
Macrophage migration inhibition test. (1970) (0)
Alternative Health Care (1984) (0)
Zebrafish embryos can activate caspase-3 prior to the maternal-zygotic transition (2004) (0)
POS0715 QUANTIFYING THE PSYCHOSOCIAL IMPACT OF UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE (UCTD) (2021) (0)
Systemic Lupus Erythematosus (2019) (0)
Women's health initiative (2002) (0)
Connective tissue diseases. Goals and strategies of management. (1986) (0)
Chapter 41 – Fertility in Systemic Lupus Erythematosus (2007) (0)
A Patient's Guide to the Antiphospholipid Syndrome (2002) (0)
The clinical management of systemic lupus erythematosus. Peter H. Schur, editor. New York, Grune & Stratton, 1983. 290 pages. Illustrated. Indexed. $39.50 (1984) (0)
Hormone replacement therapy, thrombosis, and rheumatic disease (2002) (0)
Dialogue: Increased usage of special educational services by children born to mothers with systemic lupus erythematosus and antiphospholipid antibodies (2014) (0)
Medical publishing. Will paper live on? (2010) (0)
Sex and Immunity: Do Men and Women Differ? (2004) (0)
Passing of an American College of Rheumatology collaborator and friend (1997) (0)
The Psychosocial Impact of Undifferentiated Connective Tissue Disease on Patient Health and Well-Being (2021) (0)
Afterword: Lessons learned (2008) (0)
Editor's note: Circumstances in which publication of material previously published as an “abstract” will be considered duplicate publication (2007) (0)
Impact of antiphospholipid syndrome iBook on medical students' improvement of knowledge: An international randomized controlled study. (2019) (0)
Fetal and maternal morbidity in pregnant patients with Lupus: a 10-year US nationwide analysis (2023) (0)
Grand Rounds from HSS October 2019, Volume 7, Issue 3 (2020) (0)
Pregnancy in SLE (2020) (0)
Standing and new policies and procedures for Arthritis & Rheumatism (2005) (0)
Venous thromboembolism during pregnancy. (1996) (0)
Real world experience with antiphospholipid antibodies (APL) : Comparison between antiphospholipid syndrome (Aps) and asymptomatic apl-positive patients. (2004) (0)

This paper list is powered by the following services:

Other Resources About Michael D. Lockshin

en.wikipedia.org

What Schools Are Affiliated With Michael D. Lockshin?

Michael D. Lockshin is affiliated with the following schools: